New HPV vaccine could be even more effective at protecting against cervical cancer
A new vaccine against human papillomavirus (HPV), which can cause cervical cancer, could be even more effective, according to research published in the journal Cancer Epidemology, Biomarkers, and Prevention.
The new vaccine, developed by drug maker Merck, will protect against nine strains of HPV and could be 90 percent effective. The current vaccine, GARDASIL, protects against four strains and is 70 percent effective.
Vaccination against these additional five types of HPV could be good news for women worldwide, as certain strains of HPV are more common outside of the United States and Europe — HPV 52 and 58, for example, are more common in Asia.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The new vaccine is being reviewed by the FDA, and if it is approved, it could be available sometime in 2015, Time reports.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Why is the Pentagon taking over the military’s independent newspaper?Today’s Big Question Stars and Stripes is published by the Defense Department but is editorially independent
-
How Mars influences Earth’s climateThe explainer A pull in the right direction
-
‘The science is clear’Instant Opinion Opinion, comment and editorials of the day
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts